Ophthalmic Drugs Market – Overview
Ophthalmic Drugs Market Research Report - Global Forecast till 2030 The changes in lifestyle and environment have raised the incidence of eye disorders that require medicines to treat the situation. Reports that gauge the medical device industry have been made available by Market Research Future which creates reports on several industry verticals that review the market growth and prospects. The market is on course to achieve a CAGR of 7.80 % in the approaching forecast period.
The influence of factors such as increasing awareness of eye disease and increased research funding in ophthalmology is expected to motivate the ophthalmic drugs market size in the coming years. The increased level of research into drugs for ophthalmic application is greatly inspiring the market for ophthalmic drugs in the forecast period. Moreover, the increased aging population is predicted to create additional opportunities for development in the approaching period.
Request Free Sample Copy at:
The segmentation of the ophthalmic drugs market is carried out on the basis of drug class, product, indication, type of dosage, and distribution channel. Based on indication, the ophthalmic drugs market is segmented into retinal disorders, inflammation/infection, glaucoma, dry eye, uveitis, allergies, and others. The segmentation of the market for ophthalmic drugs based on drug class comprises antiglaucoma, anti-inflammatory, antiallergy, anti-VEGF agents, and others. The anti-inflammatory segment is additionally segmented into steroidal drugs and nonsteroidal drugs. Based on the dosage, the ophthalmic drugs market is segmented into ointments, eye drops, capsules and tablets, eye solutions, and gels. By product, the ophthalmic drugs market is segmented into OTC drugs and prescription drugs. Based on the distribution channel, the ophthalmic drugs market is segmented into online pharmacies, drug stores, hospital pharmacies, and others.
Browse Detailed TOC with COVID-19 Impact Analysis at:
The central players featured in the ophthalmic drugs market are Allergan Plc, Bausch Lomb Inc., Genentech, Inc., Merck Co., Inc., Pfizer Inc., Actavis Generics, Regeneron Pharmaceuticals, Inc., Shire Plc, Sun Pharmaceutical Industries Limited, Santen Pharmaceutical Co., Ltd., Teva Pharmaceutical Industries Ltd., Valeant Pharmaceuticals International, Inc., and others.
Global Ophthalmic Drugs Market Research Report: Information by Dosage Form (Eye Drops, Eye Ointments, Eye Solutions, Gels, Capsules Tablets and others), Product Type (Prescription Drug and OTC Drug), Drug Class (Antibiotics, Anti-Inflammatory, Anti-Glaucoma and others), Indication (Glaucoma, Retinal Disorder, Dry Eye, Eye Allergy and others) and Region (Americas, Europe, Asia-Pacific and Middle East Africa) - Forecast till 2030
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071